Therefore, our study aimed to detect the serum level of CXCL-8 in patients with CRC and compare this chemokine to current tumor markers to establish whether it may be considered an improved tumor marker for CRC diagnosis. The gene discussed is CXCL8; the disease is colorectal carcinoma.